aTyr Pharma (NASDAQ:LIFE) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:00 PM.
Here’s what investors need to know about the announcement.
Earnings
aTyr Pharma beat estimated earnings by 27.5%, reporting an EPS of $-0.29 versus an estimate of $-0.4.
Revenue was down $0 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.22 which was followed by a 0.52% increase in the share price the next day.
Here’s a look at aTyr Pharma’s past performance:
| Quarter | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.48 | -0.46 | -0.38 | -0.33 |
| EPS Actual | -0.26 | -0.46 | -0.44 | -0.44 |
| Revenue Estimate | 210K | 330K | 2.00M | 170K |
| Revenue Actual | 10.39M | 0 | 0 | 0 |
To track all earnings releases for aTyr Pharma visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
